Catalan
Albanian
Arabic
Armenian
Azerbaijani
Belarusian
Bengali
Bosnian
Catalan
Czech
Danish
Deutsch
Dutch
English
Estonian
Finnish
Français
Greek
Haitian Creole
Hebrew
Hindi
Hungarian
Icelandic
Indonesian
Irish
Italian
Japanese
Korean
Latvian
Lithuanian
Macedonian
Mongolian
Norwegian
Persian
Polish
Portuguese
Romanian
Russian
Serbian
Slovak
Slovenian
Spanish
Swahili
Swedish
Turkish
Ukrainian
Vietnamese
Български
中文(简体)
中文(繁體)
intermittent claudication/cefalàlgia
L'enllaç es desa al porta-retalls
Pàgina 1 des de 48 resultats
[Hypertension, precordial pain, intermittent claudication, severe headache, chills, coma and death].
Només els usuaris registrats poden traduir articles
Inicieu sessió / registreu-vos
Headache and intermittent claudication of the jaw in temporal arteritis.
Només els usuaris registrats poden traduir articles
Inicieu sessió / registreu-vos
[SUBCUTANEOUS INJECTIONS OF CARBON DIOXIDE AND ROYAT THERMAL GASES IN ARTERIAL DISEASES (ANGINA PECTORIS, INTERMITTENT CLAUDICATION, RAYNAUD'S DISEASE, HEADACHE OF HYPERTENSIVES, ETC.)].
Només els usuaris registrats poden traduir articles
Inicieu sessió / registreu-vos
Efficacy and safety of pentoxifylline in geriatric patients with intermittent claudication.
Només els usuaris registrats poden traduir articles
Inicieu sessió / registreu-vos
The effects of pentoxifylline on intermittent claudication were evaluated at a dose of 1200 mg/day in an open-label twelve-week study on geriatric patients with chronic occlusive arterial disease (COAD). Standardized treadmill testing and clinical signs and symptoms of COAD were followed up before
Cilostazol: a novel treatment option in intermittent claudication.
Només els usuaris registrats poden traduir articles
Inicieu sessió / registreu-vos
Cilostazol is a phosphodiesterase III inhibitor with antiplatelet, antithrombotic and vasodilatory effects. It raises plasma high-density lipoprotein cholesterol levels by approximately 10% and lowers plasma triglycerides by approximately 15%. Eight US/UK randomized, multicentre, double-blind,
Pharmacotherapy of intermittent claudication.
Només els usuaris registrats poden traduir articles
Inicieu sessió / registreu-vos
Intermittent claudication (IC) is leg muscle pain, cramping and fatigue brought on by exercise and is the primary symptom of peripheral arterial disease. The goals of pharmacotherapy for IC are to increase the walking capacity/quality of life and to decrease rates of amputation. In 1988,
Effects of policosanol and ticlopidine in patients with intermittent claudication: a double-blinded pilot comparative study.
Només els usuaris registrats poden traduir articles
Inicieu sessió / registreu-vos
Policosanol is a cholesterol-lowering drug with concomitant antiplatelet effects. The present study was undertaken to compare the effects of policosanol and ticlopidine in patients with moderately severe intermittent claudication (IC). The study had a 4-week baseline step, followed by a 20-week
A dose-effect study of beraprost sodium in intermittent claudication.
Només els usuaris registrats poden traduir articles
Inicieu sessió / registreu-vos
We compared the efficacy and safety of three doses of beraprost sodium, an epoprostenol analogue, with placebo in the treatment of intermittent claudication (Fontaine's stage II). One hundred sixty-four patients were randomized to receive either placebo, 20 micrograms beraprost sodium (BPS60 group),
Cilostazol for intermittent claudication.
Només els usuaris registrats poden traduir articles
Inicieu sessió / registreu-vos
BACKGROUND
Peripheral arterial disease (PAD) affects between 4% and 12% of people aged 55 to 70 years, and 20% of people over 70 years. A common complaint is intermittent claudication, characterised by pain in the legs or buttocks that occurs with exercise and which subsides with rest. Compared with
Coital cephalgia and ischaemic muscular work of the lower limbs.
Només els usuaris registrats poden traduir articles
Inicieu sessió / registreu-vos
A case is reported of a patient who presented with coital cephalgia, and in whom an obstructive lesion of the lower aorta was demonstrated. Bicycle ergometry evoked an abnormal pressor response. The condition was cured by restoration of normal circulation. An abnormal pressor response to treadmill
Ergotamine-induced intermittent claudication.
Només els usuaris registrats poden traduir articles
Inicieu sessió / registreu-vos
We report about a female patient with intermittent claudication caused by ergotamine. She used ergotamine as a treatment for migraine headaches for more than 4 years. The claudication began 7 month before admission. Colour Doppler sonography and angiography showed severe stenosis of the left
Effect of cilostazol on walking distances in patients with intermittent claudication caused by peripheral vascular disease.
Només els usuaris registrats poden traduir articles
Inicieu sessió / registreu-vos
OBJECTIVE
This study evaluated the effects of cilostazol on walking distances in patients with intermittent claudication (IC) caused by peripheral arterial occlusive disease.
METHODS
The study was a multicenter, randomized, double-blind, placebo-controlled trial. Two hundred thirty-nine patients
Trial of a novel prostacyclin analog, UT-15, in patients with severe intermittent claudication.
Només els usuaris registrats poden traduir articles
Inicieu sessió / registreu-vos
Prostacyclin is an endothelially derived vasodilator and inhibitor of platelet aggregation. Despite its therapeutic potential for peripheral arterial disease, the short half-life and chemical instability are barriers to routine therapy. Accordingly, prostacyclin analogs are being evaluated in
A systematic review and economic evaluation of cilostazol, naftidrofuryl oxalate, pentoxifylline and inositol nicotinate for the treatment of intermittent claudication in people with peripheral arterial disease.
Només els usuaris registrats poden traduir articles
Inicieu sessió / registreu-vos
BACKGROUND
Peripheral arterial disease (PAD) is a condition in which there is blockage or narrowing of the arteries that carry blood to the legs and arms. It is estimated to affect around 4.5% of people aged between 55 and 74 years within the UK. The most common symptom of PAD is intermittent
[Cilostazol is effective and safe option for the treatment of intermittent claudication. Results of the NOCLAUD study].
Només els usuaris registrats poden traduir articles
Inicieu sessió / registreu-vos
Intermittent claudication can seriously impair the patients' quality of life. Cilostazol was registered in Hungary in 2014. This study aimed to evaluate the efficacy and safety of cilostazol in patients with intermittent claudication. 1405 patients were enrolled to the 6 months, multicenter,
La base de dades d’herbes medicinals més completa avalada per la ciència
- Funciona en 55 idiomes
- Cures a base d'herbes recolzades per la ciència
- Reconeixement d’herbes per imatge
- Mapa GPS interactiu: etiqueta les herbes a la ubicació (properament)
- Llegiu publicacions científiques relacionades amb la vostra cerca
- Cerqueu herbes medicinals pels seus efectes
- Organitzeu els vostres interessos i estigueu al dia de les novetats, els assajos clínics i les patents
Escriviu un símptoma o una malaltia i llegiu sobre herbes que us poden ajudar, escriviu una herba i vegeu malalties i símptomes contra els quals s’utilitza.
* Tota la informació es basa en investigacions científiques publicades
